CrossrefInfokarte
Residual Invasive Disease After Neoadjuvant Therapy in Triple-Negative Breast Cancer: Risk Stratification and Postoperative Radiotherapy–Pembrolizumab Integration
Cancer Management and Research · 2026-10 · Volume 18 · 1-18
DOI: 10.2147/cmar.s653901 ↗Abstract
Kein Abstract verfügbar.
EUVIMED